LivaNova (NASDAQ:LIVN) Sets New 1-Year High – Here’s What Happened

LivaNova PLC (NASDAQ:LIVN)’s share price hit a new 52-week high on Monday . The stock traded as high as $84.30 and last traded at $83.81, with a volume of 24692 shares trading hands. The stock had previously closed at $83.62.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. KeyCorp upped their target price on shares of LivaNova from $83.00 to $92.00 and gave the company an “overweight” rating in a research note on Monday, June 22nd. Weiss Ratings upgraded LivaNova from a “sell (d+)” rating to a “hold (c)” rating in a research note on Thursday, May 7th. Robert W. Baird dropped their target price on LivaNova from $78.00 to $76.00 and set an “outperform” rating for the company in a report on Thursday, May 7th. Mizuho raised their target price on LivaNova from $85.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Finally, Freedom Capital upgraded LivaNova to a “hold” rating in a research report on Tuesday, June 30th. Six research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $80.75.

LivaNova Price Performance

The company has a debt-to-equity ratio of 0.24, a current ratio of 1.33 and a quick ratio of 1.11. The stock has a market capitalization of $4.61 billion, a P/E ratio of 43.06 and a beta of 0.86. The company’s 50 day simple moving average is $73.95 and its two-hundred day simple moving average is $67.65.

LivaNova (NASDAQ:LIVN) last posted its earnings results on Wednesday, May 6th. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.13. The company had revenue of $362.26 million during the quarter, compared to analysts’ expectations of $346.05 million. LivaNova had a net margin of 7.48% and a return on equity of 16.48%. LivaNova’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.88 earnings per share. LivaNova has set its FY 2026 guidance at 4.200-4.300 EPS. As a group, equities analysts expect that LivaNova PLC will post 3.73 EPS for the current fiscal year.

Insider Buying and Selling

In other LivaNova news, Director Francesco Bianchi sold 1,800 shares of the business’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $75.75, for a total value of $136,350.00. Following the transaction, the director owned 7,228 shares of the company’s stock, valued at approximately $547,521. The trade was a 19.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.35% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in LIVN. Millennium Management LLC lifted its position in LivaNova by 17.3% during the 4th quarter. Millennium Management LLC now owns 3,484,082 shares of the company’s stock worth $214,376,000 after buying an additional 514,268 shares in the last quarter. Wellington Management Group LLP increased its position in LivaNova by 83.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,345,516 shares of the company’s stock valued at $122,858,000 after acquiring an additional 1,067,349 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of LivaNova by 1.5% in the fourth quarter. Vanguard Group Inc. now owns 2,332,051 shares of the company’s stock worth $143,491,000 after acquiring an additional 34,812 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of LivaNova by 29.9% in the fourth quarter. AQR Capital Management LLC now owns 2,155,142 shares of the company’s stock valued at $132,606,000 after purchasing an additional 496,165 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of LivaNova by 2.1% in the first quarter. Dimensional Fund Advisors LP now owns 1,826,248 shares of the company’s stock valued at $116,067,000 after purchasing an additional 38,320 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

LivaNova Company Profile

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.